THURSDAY, Aug. 8, 2024 -- Increased glycated hemoglobin (HbA1c) stability within patient-specific target ranges is associated with a lower risk for...
Vous n'êtes pas connecté
TUESDAY, July 9, 2024 -- Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published...
THURSDAY, Aug. 8, 2024 -- Increased glycated hemoglobin (HbA1c) stability within patient-specific target ranges is associated with a lower risk for...
A small study led by researchers at Johns Hopkins Medicine, published on July 25th in Nature Cardiovascular Research, has uncovered how obesity...
THURSDAY, Aug. 8, 2024 -- For patients with HIV in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial, use of abacavir was...
FRIDAY, Aug. 2, 2024 -- Use of the Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations instead of the 2013 recommended pooled cohort...
TUESDAY, Aug. 6, 2024 -- Vestibular neurectomy is an effective vertigo treatment in patients with severe Meniere disease, according to a study...
FRIDAY, Aug. 16, 2024 -- Patients with skin of color may experience more adverse events from sclerotherapy, according to a study published online...
MONDAY, Aug. 5, 2024 -- For patients with Meniere disease (MD), vestibular neurectomy is effective, resolving vertigo episodes and resulting in...
For patients with type 2 diabetes mellitus (T2DM) who also have tobacco use disorder (TUD), a new study suggests that using semaglutide is linked to a...
TUESDAY, Aug. 6, 2024 -- City-level excise taxes on sugar-sweetened beverages (SSBs) are associated with lower body mass index (BMI) among youths,...
TUESDAY, Aug. 13, 2024 -- Tailored text messages may encourage an increase in physical activity in patients undergoing cardiac rehabilitation,...